If I'd invested $1,000 in CSL shares 24 years ago, here's how much I'd have now!

While some companies have lost value or even collapsed since listing, you might be surprised how many ASX 200 shares have rocketed over the long term.

| More on:
Woman looks amazed and shocked as she looks at her laptop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

CSL Ltd (ASX: CSL) shares first listed on the ASX way back on 8 June 1994.

The S&P/ASX 200 Index biotechnology company floated for $2.30 per share. But once we take share buybacks into account, the adjusted entry price works out to around 76 cents per share.

We won't go back quite that far.

But here's how much I'd have now if I'd invested $1,000 in CSL shares 24 years ago.

Invest in CSL shares like it's 1999

Investing with perfect hindsight is a wonderful thing.

While some companies have lost value or even collapsed since listing, you might be surprised how many ASX 200 shares have rocketed over the long term.

CSL shares certainly count among the winners.

Back on 16 April 1999, CSL closed the day trading for $4.23 per share.

That means I could have bought 236 shares with my $1,000 and had enough left over for a cup of 1999-priced coffee.

At the time of writing, CSL is trading for $304.31 per share.

If I opted to sell those 236 shares today they'd get me a whopping $71,817 and change.

In other words, the stock would have seen me gain 7,081% on my initial investment over 24 years, from share price appreciation alone.

Don't forget the dividends!

But let's not forget that CSL shares also have a lengthy track record of delivering dividends.

According to my calculations, the biotech company has paid out approximately $28 per share in dividends since April 1999. That's more than six times what I would have paid for those shares in 1999.

Assuming I didn't reinvest those dividends but simply tucked the cash under my mattress for a rainy day, I'd have earned some $6,608 in passive income from my 236 shares.

Adding that in, my total gains on that $1,000 investment in 1999 have leapt to an eye-popping 7,742%.

Granted, inflation over that period will have cut those gains roughly in half in real terms.

But still, try getting that kind of yield from your bank!

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Scientists working in the laboratory and examining results.
Healthcare Shares

Insider still buying Mesoblast shares despite 230% rise this year: Should you buy?

This high-flying share is still reporting insider buying. Should you buy too?

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

Buy CSL shares for growing dividends and 'compelling long-term tailwinds'

CSL has increased both its interim and final dividend every year since 2021.

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

Resmed share price higher despite CEO hitting sell on 14,683 shares

ResMed's CEO just sold $4.8 million worth of his own company's shares.

Read more »

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Why this high-flying ASX 200 healthcare stock just crashed 11%

Neuren Pharmaceuticals just dropped its 1Q FY24 report on DAYBUE sales.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Bell Potter says this ASX biotech stock could rocket 80%

Investors with a high tolerance for risk may want to check out this stock.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Healthcare Shares

This ASX 200 healthcare stock is rocketing 8% following a record month!

Investors are impressed with this update. Here's why.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

3 reasons CSL stock is a great long-term investment

CSL has been a high-performing stock. Is it a buy today? UBS has the answer.

Read more »

Shot of a mature scientists working on a laptop in a lab.
Healthcare Shares

Down 10% since mid-March, are Medibank shares a buy or a sell?

Is this stock a healthy opportunity?

Read more »